Intranasal and intramuscular naloxone for opioid overdose in the pre-hospital setting a review of comparative clinical and cost-effectiveness, and guidelines
In 2017, CADTH produced a Rapid Response report summarizing evidence on the comparative clinical effectiveness, cost effectiveness, and evidence-based recommendations for use of the various formulations and delivery mechanisms of naloxone for the treatment of opioid poisoning in pre-hospital settion...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
CADTH
November 26, 2019, 2019
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | In 2017, CADTH produced a Rapid Response report summarizing evidence on the comparative clinical effectiveness, cost effectiveness, and evidence-based recommendations for use of the various formulations and delivery mechanisms of naloxone for the treatment of opioid poisoning in pre-hospital settiongs. The evidence available then for that report was limited in number and quality. Therefore, the objective of this current Rapid Response report is to review any new evidence that may have become available since the 2017 report and update the evidence |
|---|---|
| Physical Description: | 1 PDF file (20 pages) illustration |